Training session on Hepatitis C Elimination by Full Cooperation of China
Hepatitis C Elimination Alliance Public Welfare Project was held in Shengjing
Hospital of China Medical University on June 23,2021. More than 300 people
including director Li Mingyang from China Liver Health, executive vice chairman
Liu Yunhui, director Zhang Xiuyue, prof. Dou Xiaoguang, prof. Ding Yang, prof. Huang
Fen and prof. Zhang Lin from Shengjing Hospital, as well as relevant personnel from infection management office,
infectious department,internal Medicine department, surgical department, gynecology department and pediatric department of the hospital attended the meeting.Zhang
Xiuyue,director of hospital infection management
office, presided over the meeting. Executive vice chairman Liu Yunhui delivered a
speech, extended welcomes to the implementation of eliminating hepatitis C
project in the hospital, which aims to contribute to the elimination of public
health threat hepatitis C by 2030.
Since 2015,Shengjing Hospital of China Medical University
has achieved steady progress in hepatitis C screening,diagnosis and treatment.(1)Issued
the documents of hepatitis C screening and management,clarified the screening
and management process of hepatitis C cases in the hospital.(2)Developed the
EMR platform for monitoring and early warning of hepatitis C and LIS system for
early warning reminder and inquiry with the informatization advantages of
hospital, to monitor Anti-HCV screening rate, HCV-RNA detection rate, hepatitis
C consultation rate and hepatitis C reporting rate of inpatient and
outpatients.(3)Participated in the project of national hepatitis C screening and
management standardization promotion, carried out publicity and training on
standardized hepatitis C screening throughout the hospital, and conducted
lectures in key departments;(4)Adopted various forms to strengthen the
publicity of hepatitis C screening to patients and staff.(5) Included the
quality of hepatitis C screening in the department evaluation and KPI
performance assessment with the publicity and feedback on the office network,
reported the screening data and the problems regularly at the meeting of the
hospital. With a series of measures, the concept and effect of hepatitis C
screening and management in the hospital had been greatly improved. In the training session, prof.
Zhang Xiuyue and prof. Dou Xiaoguang gave lectures respectively on Management
Process of Hepatitis C Hospital Screening of China, and Hepatitis C Epidemiology
and Prevention,emphasized the necessity and importance of management of
hepatitis C patients, interpreted and summarized the specific screening and
management process of hepatitis C patients in Shengjing Hospital of China Medical University. Prof. Dou Xiaoguang answered
questions Answered questions about
hepatitis C put forward by the medical staff on site At the meeting, Li Mingyang,director
of China Liver Health introduced China Liver Health and the arrangements of China Hepatitis C Elimination
Alliance Public Welfare Project. Launched in the Great Hall of the People in
Beijing in September 2017, the project is committed to carrying out a series of
large-scale public welfare activities under the guidance of the Ministry of
Civil Affairs, Bureau of Disease Prevention and Control under National Health
Commission and China CDC. With academician Zhuang Hui serving as the general counsel
and prof.Wei Lai as the chief expert, it aims to promote hepatitis C screening
and detection and standardizing diagnosis and treatment in China, facilitate
the realization of the goal of eliminating viral hepatitis as a public health
threat by 2030 put forward by WHO, and contribute to building Healthy China.
More over, he conferred the plaque of diagnosis and
treatment base of China
Hepatitis C Elimination Alliance Public Welfare Project to Shengjing Hospital
of China Medical University, and appointed Dou Xiaoguang, Zhang Xiuyue, Wang
Fei, Ding Yang and Huang Fen as members of the National Expert Committee for
Liver Health Promotion. Conferred
the plaque of diagnosis and treatment base of China Hepatitis C Elimination Alliance Public Welfare
Project Appointment
ceremony of members of the National Expert Committee for Liver Health Promotion The event was public welfare
supported by Gilead Science Inc. |